Director Tim Terpstra appointed
IMPACT BIOMEDICAL INC. appointed Tim Terpstra as a director. This brings experienced executive leadership to the board to oversee company operations.
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
IMPACT BIOMEDICAL INC. appointed Tim Terpstra as a director. This brings experienced executive leadership to the board to oversee company operations.
Standard Motor Products CFO Nathan Iles resigned effective Oct 30 and will be replaced by former CFO James Burke. The company announced a conference call for Q3 2026 earnings.
Joseph M. Cohen was appointed to the Company's Board and committees effective Oct. 9, 2026.
Former SVP Peter Williams received a $593,750 separation package after departing on Sep 11, 2026. The firm's HR Chief and Founder Christopher Fisher died on Oct 16, 2026.
Myriad Genetics Inc. has separated from its Chief Commercial Officer, Brian Donnelly, effective September 21, 2026. The departure is part of a separation agreement resulting in a l…
Vogenx named board member Richard Gorman as Chief Commercial Officer, tapping his 30-year biopharmaceutical experience to strengthen its commercial strategy and readiness following…
Zedge, Inc. entered into an employment agreement with Morris Berger effective October 1, 2026. The hiring represents a strategic leadership addition for the mobile content company …
Enerpac Tool Group (NYSE: EPAC) announced the appointment of Charles T. Lauber to its board of directors. The addition of the seasoned finance executive is expected to enhance the …
Applied Energetics reported significant performance improvements to ultrashort-pulse laser technology, boosting range for counter-drone systems and advancing viability for portable…
Stride agreed to add Directors Dylan Haggart and Steven Guttentag to its board, expanding governance under a cooperation agreement with Fivespan Partners, reflecting a major govern…
Quince Therapeutics Inc. has amended its certificate of incorporation to change its corporate name to IRulya Therapeutics Inc. ahead of an October 9, 2026, effective date. The boar…
Avient Corporation announced the appointment of Mike Frank as President and Chief Executive Officer, succeeding Dr. Ashish K. Khandpur, while Richard H. Fearon was elected Non-Exec…
Byline Bancorp appointed Sean H. McGuire and Scott E. Hawthorne to new executive roles while departing executives Ptacin and Fucinato retire. Market remains focused on succession p…
Independent Contractor Agreement executed with Dwight Erdbruegger running from Oct. 7 to Dec. 31, 2026.
Sezzle will release third quarter results on November 4, 2026, and participate in five investor conferences. The announcement highlights upcoming earnings call details and manageme…
Tenax Therapeutics released its corporate presentation for October 2026 following the failure of the Phase 3 LEVEL trial to meet its primary endpoint. A new study, LEVEL-2, was ann…
Aardvark appointed biotech executive David Zhang to its board to aid development of ARD-101 for Prader-Willi Syndrome. Leadership appointments positively impact biopharma company s…
The Federal Home Loan Bank of New York reported $70.9 million in Affordable Housing Program grants and expanded initiatives for 2026. The bank launched the 2026 Member Satisfaction…
AGNT Inc. announced immediate leadership succession with Leo Pareja as CEO and founder Glenn Sanford moving to Chairman, a move aimed at guiding the company's next chapter of AI-na…
RB Global announced the promotion of Steve Steinberg to CFO and the creation of a new Chief Digital and Strategy Officer role as it targets strong results in 2026.